Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-02 Sale | 2026-03-04 6:54 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 42,434 | $8.2659 | $350,755 | 377,450 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 6:53 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 42,442 | $8.2659 | $350,821 | 412,015 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 6:52 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 30,800 | $8.2659 | $254,590 | 333,469 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 6:51 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 156,235 | $8.1734 | $1,276,971 | 2,704,496 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 6:51 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 42,431 | $8.2659 | $350,730 | 494,197 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 4:28 pm | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 30,000 | $8.03 | $240,900 | 93,469 (Direct) | View |
| 2025-08-07 Purchase | 2025-08-08 4:05 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.15 | $41,500 | 2,335,731 (Direct) | View |
| 2025-06-13 Sale | 2025-06-16 9:10 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 7,000 | $4.59 | $32,130 | 97,082 (Direct) | View |
| 2025-05-21 Purchase | 2025-05-21 9:23 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.3995 | $43,995 | 2,325,731 (Direct) | View |
| 2025-05-16 Purchase | 2025-05-19 5:13 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 20,000 | $4.2236 | $84,472 | 2,315,731 (Direct) | View |
| 2025-03-06 Purchase | 2025-03-06 5:53 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $5.015 | $50,150 | 2,295,731 (Direct) | View |
| 2025-03-05 Purchase | 2025-03-05 5:19 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $5.02 | $50,200 | 2,285,731 (Direct) | View |
| 2025-03-03 Purchase | 2025-03-04 4:45 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.705 | $47,050 | 2,275,731 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-04 Option Award | 2026-06-08 4:39 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | McGuire Daniel Patrick SVP, GC and Secretary | 80,000 | $0 | 109,982 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:23 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 41,600 | $0 | 164,950 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:21 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Duncan Charles Cliff Director | 41,600 | $0 | 98,701 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:20 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 41,600 | $0 | 219,054 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:19 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 41,600 | $0 | 160,667 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:17 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 41,600 | $0 | 135,069 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:15 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 41,600 | $0 | 112,846 (Direct) | View |
Ownership | 2026-06-08 4:12 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | McGuire Daniel Patrick SVP, GC and Secretary | 0 | $0 | 29,982 (Direct) | View |
| 2026-05-18 Gift | 2026-05-20 4:49 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 25,836 | $0 | 71,246 (Direct) | View |
| 2026-04-22 Option Award | 2026-04-24 4:36 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Duncan Charles Cliff Director | 57,101 | $0 | 57,101 (Direct) | View |
Ownership | 2026-04-13 5:38 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Christos Vasilios Mihael Senior VP, Medical Director | 0 | $0 | 447,441 (Direct) | View |
Ownership | 2026-04-13 5:37 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Howell Scott Laverne VP and Chief People Officer | 0 | $0 | 534,455 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-19 5:53 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 125,000 | $0 | 364,269 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-19 5:51 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 125,000 | $0 | 536,628 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-19 5:50 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 125,000 | $0 | 419,884 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-19 5:48 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 125,000 | $0 | 454,457 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-19 5:46 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 525,000 | $0 | 2,860,731 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:36 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 59,225 | $0 | 104,082 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:35 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 59,225 | $0 | 123,350 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:35 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 59,225 | $0 | 177,454 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:34 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 59,225 | $0 | 123,469 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:34 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 59,225 | $0 | 119,067 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:46 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 15,520 | $4.76 | 239,269 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:46 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 26,941 | $4.76 | 411,628 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:45 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 95,999 | $4.76 | 2,275,731 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:45 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 26,941 | $4.76 | 329,457 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:44 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 26,941 | $4.76 | 294,884 (Direct) | View |